HomeSBHMY • OTCMKTS
Sino Biopharmaceutical Unsponsored Caymand Islands ADR
$9.05
Nov 27, 12:20:21 AM GMT-5 · USD · OTCMKTS · Disclaimer
US listed security
Previous close
$9.05
Year range
$6.69 - $9.65
Market cap
61.81B HKD
Avg Volume
50.00
CDP Climate Change Score
B
In the news
Financials
Income Statement
Revenue
Net income
(CNY)Jun 2024Y/Y change
Revenue
7.94B11.14%
Operating expense
4.78B10.58%
Net income
1.51B139.69%
Net profit margin
19.01115.78%
Earnings per share
EBITDA
1.98B8.88%
Effective tax rate
16.99%
Total assets
Total liabilities
(CNY)Jun 2024Y/Y change
Cash and short-term investments
13.18B-15.93%
Total assets
66.70B1.62%
Total liabilities
24.58B-15.76%
Total equity
42.12B
Shares outstanding
18.21B
Price to book
5.03
Return on assets
6.50%
Return on capital
8.37%
Net change in cash
(CNY)Jun 2024Y/Y change
Net income
1.51B139.69%
Cash from operations
1.54B15.25%
Cash from investing
-1.02B49.91%
Cash from financing
-2.05B-1.42%
Net change in cash
-1.52B43.37%
Free cash flow
1.09B36.59%
About
Sino Biopharmaceutical Limited, shortly Sino Biopharm, is a civilian-run enterprise principally engaged in the medicine products business in Mainland China. Being a member of Charoen Pokphand Group and headquartered in Hong Kong and Beijing, Sino Biopharm is engaged in researching, developing, producing, and selling biopharmaceutical products for the medical treatment of ophthalmia, as well as modernized Chinese medicine and chemical medicine for the treatment of hepatitis through its subsidiaries. Sino Biopharm is also involved in other minor businesses through its subsidiaries, such as properties, health food, optical glass, optical and auditory products. Wikipedia
Founded
2000
Employees
24,437
Discover more
You may be interested in
This list is generated from recent searches, followed securities, and other activity. Learn more

All data and information is provided “as is” for personal informational purposes only, and is not intended to be financial advice nor is it for trading purposes or investment, tax, legal, accounting or other advice. Google is not an investment adviser nor is it a financial adviser and expresses no view, recommendation or opinion with respect to any of the companies included in this list or any securities issued by those companies. Please consult your broker or financial representative to verify pricing before executing any trades. Learn more
Search
Clear search
Close search
Google apps
Main menu